Antiphospholipid antibodies induced by interferon-alpha in patients with hepatitis C virus infection

被引：0
|
作者：
Doutre, MS
Baquey, A
Bernard, P
Couzigou, P
Bernard, N
Lacoste, D
Morlat, P
机构：
[1] HOP PELLEGRIN,IMMUNOL LAB,F-33076 BORDEAUX,FRANCE
[2] HOP ST ANDRE,SERV HEPATOGASTROENTEROL,F-33076 BORDEAUX,FRANCE
[3] HOP HAUT LEVEQUE,SERV HEPATOGASTROENTEROL,F-33604 PESSAC,FRANCE
[4] HOP ST ANDRE,SERV MED INTERNE,F-33076 BORDEAUX,FRANCE
来源：
ANNALES DE MEDECINE INTERNE | 1997年 / 148卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [31] Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C.
    Hasegawa, I
    Orito, E
    Tanaka, Y
    Hirashima, N
    Sakakibara, K
    Ohno, T
    Sugauchi, F
    Suzuki, S
    Sakurai, M
    Fujiwara, K
    Ozasa, T
    Ueda, R
    Mizokami, M
    [J]. HEPATOLOGY, 2002, 36 (04) : 369A - 369A
  • [32] Detectable levels of IgM antibodies to hepatitis C virus core protein predict breakthrough in patients with chronic hepatitis C treated with interferon-alpha
    Fracassetti, O
    Tambini, R
    Perani, V
    Vicari, O
    Lorenzi, N
    Delvecchio, G
    [J]. JOURNAL OF VIRAL HEPATITIS, 1996, 3 (05) : 265 - 266
  • [33] CHRONIC HEPATITIS-B VIRUS-INFECTION AND INTERFERON-ALPHA
    GOESER, T
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (10) : 1793 - 1794
  • [34] Intravenous interferon-alpha treatment of mixed cryoglobulinemia associated with chronic hepatitis C virus infection
    Zeller, V
    Cohen, P
    Nguyen, QT
    Lebon, P
    Dziri, S
    Ferrière, F
    Dény, P
    Guillevin, L
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (04) : 573 - 574
  • [35] Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4
    ElZayadi, A
    Simmonds, P
    Dabbous, H
    Prescott, L
    Selim, O
    Ahdy, A
    [J]. JOURNAL OF VIRAL HEPATITIS, 1996, 3 (05) : 261 - 264
  • [36] FACTORS PREDICTIVE OF RESPONSE TO INTERFERON-ALPHA THERAPY IN HEPATITIS-C VIRUS-INFECTION
    TSUBOTA, A
    CHAYAMA, K
    IKEDA, K
    YASUJI, A
    KOIDA, I
    SAITOH, S
    HASHIMOTO, M
    IWASAKI, S
    KOBAYASHI, M
    HIROMITSU, K
    [J]. HEPATOLOGY, 1994, 19 (05) : 1088 - 1094
  • [37] Hepatitis C virus infection in kidney transplantation and a pilot study of the effects of interferon-alpha therapy
    Hanafusa, T
    Ichikawa, Y
    Yazawa, K
    Kishikawa, H
    Fukunishi, T
    Kanai, T
    Shinji, Y
    Nagano, S
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (01) : 122 - 124
  • [38] Treatment of chronic hepatitis C with Interferon-alpha in patients infected with the human immunodeficiency virus
    Mauss, S
    Heintges, T
    Adams, O
    Albrecht, H
    Niederau, C
    Jablonowski, H
    [J]. HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 528 - 534
  • [39] MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH HEPATITIS-C VIRUS-INFECTION RESPONSIVE TO INTERFERON-ALPHA
    YAMABE, H
    JOHNSON, RJ
    GRETCH, DR
    OSAWA, H
    INUMA, H
    SASAKI, T
    KAIZUKA, M
    TAMURA, N
    TSUNODA, S
    FUJITA, Y
    SATO, A
    ONODERA, K
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (01) : 67 - 69
  • [40] Interferon-alpha induced transient thyroid dysfunction in hepatitis C
    Fernández-Díez, S
    Rodríguez-Agulló, JL
    Rielo, MJC
    Angulo, NN
    Díaz-Rubio, M
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2002, 94 (03) : 162 - 163
12345